Hand and Arm Motor Recovery Via Non-invasive Electrical Spinal Cord Stimulation After Stroke

NCT ID: NCT05591196

Last Updated: 2025-03-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

6 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-10-01

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The recovery from a stroke is often incomplete. It is the leading cause of acquired permanent disability in the adult population. Persistent functional loss of the hand and arm contributes significantly to disability. However, the current standard of care to treat hand and arm movements are inadequate. There is an urgent need for innovative and effective therapies for recovery of the upper limb after stroke.

Growing evidence shows that electrical spinal cord stimulation, combined with activity-dependent rehabilitation, enables voluntary movement of paralyzed muscles in some neurologic disorders, such as spinal cord injury. The investigators hypothesize that spinal networks that lost control after stroke can be activated by non-invasive electrical stimulation of the spinal cord to improve functional recovery.

The aims of the study are:

1. to determine the improvements in hand and arm function that result from the combined application of non-invasive spinal stimulation and activity-based rehabilitation. Surface electrodes placed over the skin of the neck will be used for non-invasive electrical stimulation of the spinal cord. Functional task practice will be used for activity-dependent rehabilitation,
2. to evaluate long-lasting benefits to hand and arm function that persist beyond the period of spinal stimulation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke, Ischemic Chronic Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Prospective, randomized, two-arm cross-over study: All participants will receive one of the two treatment arms one after the other. The order of the treatments will be randomized.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Activity Based Rehabilitation

Activity Based Rehabilitation is comprised of intensive, progressive, functional task practice. The protocol consists of repetitive activities of gross upper limb movement, isolated finger movements, bimanual task performance, simple and complex pinch, and grip performance. Several activities with various difficulty levels are designated for each category, and the participant will perform 1-2 activities within each category in each rehabilitation session. Rehabilitation sessions will be three times per week, 90 minutes per session for six weeks (total of 18 sessions).

Group Type ACTIVE_COMPARATOR

Activity Based Rehabilitation

Intervention Type OTHER

Exercise therapy targeting paralyzed hand and arm

Non-invasive Electrical Spinal Cord Stimulation + Activity Based Rehabilitation

Non-invasive electrical spinal cord stimulation will be performed using surface electrodes placed over the skin of the neck. Biphasic rectangular pulses of 1 millisecond per phase duration will be delivered with a 10 kiloHertz overlapping frequency and between 20-120 Hertzz burst frequency. Non-invasive electrical spinal cord stimulation will be paired with Activity Based Rehabilitation sessions. Stimulation plus rehabilitation sessions will be three times per week, 90 minutes per session for six weeks (total of 18 sessions).

Group Type EXPERIMENTAL

Non-invasive Electrical Spinal Cord Stimulation

Intervention Type DEVICE

Electrical stimulation of the spinal cord using surface electrodes

Activity Based Rehabilitation

Intervention Type OTHER

Exercise therapy targeting paralyzed hand and arm

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Non-invasive Electrical Spinal Cord Stimulation

Electrical stimulation of the spinal cord using surface electrodes

Intervention Type DEVICE

Activity Based Rehabilitation

Exercise therapy targeting paralyzed hand and arm

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Radiologically documented single ischemic stroke resulted in hemiplegia/hemiparesis
* At least six months post-stroke
* Upper Extremity Fugl-Meyer Assessment score "moderate" or "moderate-mild" (29-53 inclusive out of 66) at the screening visit
* Medically and neurologically stable, as determined by medical history and documented physical examination
* For women of childbearing potential, a negative over-the-counter pregnancy test at study entry and willingness to practice adequate contraception during the study
* Ability to attend sessions three times per week
* Adequate social support to participate in all intervention and baseline, follow-up assessment sessions throughout eight months.
* Ability to read, comprehend and speak English

Exclusion Criteria

* Hemorrhagic stroke
* History of multiple strokes
* Active implanted stimulator (e.g., pacemaker, vagus nerve stimulator, cochlear implant, etc.) or baclofen pump
* Aphasia or any other deficit in communication that interferes with reasonable study participation
* Moderate to severe cognitive impairment
* Presence of neglect (inability to perceive or awareness of, or loss of attention to the weaker half of the body)
* Severe spasticity in the upper limb
* Taking baclofen more than 30 mg/day
* Change in baclofen dose within four weeks before enrollment
* Receiving benzodiazepines, dantrolene, tizanidine, anticoagulant, or antiepileptic medication
* Botulinum toxin injection to the upper limb muscles within six months before enrollment
* Severe joint contractures in the affected hand and arm
* History of spontaneous seizure that had occurred one month or longer after the stroke
Minimum Eligible Age

21 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Washington

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Chet Moritz

Associate Professor, Electrical and Computer Engineering, Rehabilitation Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chet Moritz, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Washington

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Washington

Seattle, Washington, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Fatma Inanici

Role: CONTACT

206-787-2692

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Fatma Inanici, MD, Ph.D.

Role: primary

2067872692

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

STUDY00015990

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Source of Hand Weakness After Stroke
NCT00907829 WITHDRAWN PHASE2